Natera (NTRA) Capital Expenditures Growth (3y) (2017 - 2026)
Natera (NTRA) Capital Expenditures Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | -6.49% |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | -3.55% |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 10.06% |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | 7.36% |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | 139.42% |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | -5.23% |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | -1.12% |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 9.89% |
| 10 | Labcorp Holdings | 25.86 Bn | 24.87 Bn | 1.01 Bn | 15.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.42% |
| Dec 31, 2025 | 45.02% |
| Sep 30, 2025 | -12.84% |
| Jun 30, 2025 | 652.75% |
| Mar 31, 2025 | 118.33% |
| Dec 31, 2024 | -20.51% |
| Sep 30, 2024 | 292.87% |
| Jun 30, 2024 | 97.65% |
| Mar 31, 2024 | -77.82% |
| Dec 31, 2023 | -15.72% |
| Sep 30, 2023 | 47.73% |
| Jun 30, 2023 | 35.46% |
| Mar 31, 2023 | -15.33% |
| Dec 31, 2022 | 47.98% |
| Sep 30, 2022 | 136.62% |
| Jun 30, 2022 | -29.84% |
| Mar 31, 2022 | 119.20% |
| Dec 31, 2021 | 196.31% |
| Sep 30, 2021 | -20.87% |
| Jun 30, 2021 | -156.41% |